Please assess the completion status of the following clinical trial:

Trial Title: Trial of Second Generation Designer T Cells in Colorectal Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Must have cancer of the colon or rectum~* Must have metastatic or unresectable locally advanced disease~* Tumor must express CEA by tumor staining or by elevated serum CEA (\>10 ng/ml)~* Must have measurable disease radiologically or by physical exam~* Must have failed potentially curative standard therapy~* Must be 18 years of age or older~* Good performance status (PS 0-1)~Exclusion Criteria:~* Requiring systemic steroids~* Serious medical conditions~* Concurrent malignancies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Gene Modified T Cells (Type: EXPERIMENTAL): Modified T cells

Based on this trial design, predict the completion outcome and termination type (if applicable).